Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolation. [electronic resource]
- Future oncology (London, England) 2015
- 61-71 p. digital
Publication Type: Journal Article; Meta-Analysis
1744-8301
10.2217/fon.14.187 doi
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized--drug effects Antineoplastic Combined Chemotherapy Protocols--therapeutic use Breast Neoplasms--drug therapy Clinical Trials as Topic Disease-Free Survival Female Humans Neoadjuvant Therapy Trastuzumab